返回
摘要
En
Keyword:
INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY
PLAQUE-TYPE PSORIASIS
QUALITY-OF-LIFE
DOUBLE-BLIND
SKIN
EFFICACY
SAFETY
TRIAL
METAANALYSIS
EXPRESSION
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
101.8
论文数:
5.1K
被引数:
5.3W
机构
引用论文
Disease severity, quality of life and health care in plaque-type psoriasis:: A multicenter cross-sectional study in Germany
DERMATOLOGY
IF2.7
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial
LANCET
IF88.5
Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis德国银屑病关节炎的流行病学和临床模式: 1511例斑块型银屑病患者的前瞻性跨学科流行病学研究
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
LANCET
IF88.5

